Intellectual property rights (IPR) in collaborative drug development in the EU: helping a European public-private partnership deliver - the need for a flexible approach to IPR.

›

Author: Laverty, Hugh

Linked as:

Document options

Printable page
Email this

Extract

Intellectual property rights (IPR) in collaborative drug development in the EU: helping a European public-private partnership deliver - the need for a flexible approach to IPR.

No longer available (Autolink)

See the full content of this document